The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: A meta-analysis of 13 randomized controlled trials

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 8, 2010, Pages 713-721

  Qin, Yuan Han ^a   Zhou, Tian Biao ^a   Su, Li Na ^a   Lei, Feng Ying ^a   Zhao, Yan Jun ^a   Huang, Wei Fang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

acute idiopathic thrombocytopenic purpura; high dose intravenous immunoglobulin; low dose intravenous immunoglobulin; meta analysis

Indexed keywords

IMMUNOGLOBULIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LOW DRUG DOSE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78349306455     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283401490     Document Type: Review

References (32)

1. Vranou M, Platokouki H, Pergantou H, Aronis S. Recurrent idiopathic thrombocytopenic purpura in childhood. Pediatr Blood Cancer 2008; 51:261-264.
2. Shahgholi E, Vosough P, Sotoudeh K, Arjomandi K, Ansari S, Salehi S, et al. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Indian J Pediatr 2008; 75:1231-1235.
3. Warrier I, Bussel JB, Valdez L, Barbosa J, Beardsley DS. Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group. J Pediatr Hematol Oncol 1997; 19:197-201.
4. Paran D, Herishanu Y, Elkayam O, Shopin L, Ben-Ami R. Venous and arterial thrombosis following administration of intravenous immunoglobulins. Blood Coagul Fibrinolysis 2005; 16:313-318.
5. Bussel JB. The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura. Clin Immunol Immunopathol 1989; 53:S147-155.
6. Zhang ZN. Blood disease diagnosis and efficacy of the standard. Beijing: Beijing Sci Press; 1998, pp. 279-285.
7. Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1:1228-1231.
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing thequality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12.
9. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344:703-707.
10. Xue TY. Comparison of the effects of different dose of gamma globulin on acute idiopathic thrombocytopenic purpura in children. Acad Med Xuzhou 2000; 20:134-135.
11. Xiang YJ, Wang JL. Effectiveness of sub-IVIG for idiopathic thrombocytopenic purpura. Zhejiang Clin Med 2002; 4:517.
12. Benesch M, Kerbl R, Lackner H, Berghold A, Schwinger W, Triebl-Roth K, Urban C. Low-doseversus high-dose immunoglobulinforprimarytreatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-centertrial. J Pediatr Hematol Oncol 2003; 25:797-800.
13. Wang J, Zhang MF, Niu JH. Clinical observationofthetherapeuticeffectsof different dose intravenous gammaglobulin in treating children with severe idiopathic thrombocytopenic purpura (ITP). Chin J Coal Industry Med 2003; 1:80.
14. Zhang SW. Observation on efficacy of N-HD-IVIG on severe idiopathic thrombocytopenic purpura. Mod Diagn Treat 2004; 15:248-249.
15. Tang GH.Therapeuticeffectsof intravenousgammaglobulinadministration for idiopathic thrombocytopenic purpura. Mod Med Hyg 2006; 22:3292-3293.
16. Huang AM, Wang YC, Zhu HL. Clinical observation of the therapeutic effect of combination sub-dose gamma globulin with glucocorticoid in children with idiopathic thrombocytopenic purpura. Mod J Integr Tradit Chin West Med 2007; 16:2828-2829.
17. Cao WB, Ji YH. Clinical observation of the curative effect of sub-standard-dose gamma globulin plus glucocorticoid in patient with idiopathic thrombocytopenic purpura. Chin J Tradit Chin Med West Med Crit Care 2007; l:249.
18. Zhu FY, Zhang Z, Cao ZH, Jiang ZP. Comparative study of intravenous gammaglobulin administration for thrombocytopenic purpura. Chin Contemp Med Sci 2007; 6:1-2.
19. Xue AM, Qiao YN, Cao HZ. Observation of the effects of sub-dose intravenousgammaglobulin administration foridiopathicthrombocytopenic purpura in children. J Med Theor Prac 2007; 20:952.
20. Ge SB. Analysis of combination therapy using sub-dose intravenous gammaglobulin in patient with idiopathic thrombocytopenic purpura in clinical practice. China Prac Med 2009; 4:148.
21. Yang ZR. Treatment of severe idiopathic thrombocytopenic purpura with two different doses of gamma globulin. J Clin Intem Med 2009; 26:569-570.
22. Imbach P, Wagner HP, Berchtold W, Gaedicke G, Hirt A, Joller P, et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 1985; 2:464-468.
23. Rosthoj S, Nielsen S, Pedersen FK. Randomized comparison of intravenous immunoglobulin and methylprednisolone pulse therapy in children with newly diagnosed idiopathic thrombocytopenia purpura. Danish ITPStudy Group. Ugeskr Laeger 1998; 160:1640-1644.
24. Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute thrombocytopenic purpura. J Pediatr 1993; 123:989-995.
25. Erduran E,Aslan Y, Gedik Y, Orhan F.Arandomized and comparativestudy of intravenous immunoglobulin and mega dose methylprednisolone treatment in children with acute idiopathic thrombocytopenic purpura. Turk Pediatr 2003; 45:295-300.
26. Ancona KG, Parker RI, Atlas MP, Prakash D. Randomized trial of high-dose methylprednisoloneversus intravenous immunoglobulinforthetreatmentof acute idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2002; 24:540-544.
27. Negi VS, Elluru S, Sibéril S, Graff-Dubois S, Mouthon L, Kazatchkine MD, et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 2007; 27:233-245.
28. Seifried E, Pindur G, Stötter H, Wiesneth M, Rasche H, Heimpel H. Treatment of refractory chronic idiopathic thrombocytopenic purpura with high dose intravenous immunoglobulin. Blut 1984; 48:369-376.
29. Cohen JI. Gammaglobulin for idiopathic thrombocytopenic purpura. N Engl J Med 1982; 307:1150-1151.
30. Emmerich B, Hiller E, Woitinas F, Maubach PA, Riess H, Nerl C, et al. Dose-response relationship in the treatment of idiopathic thrombocytopenic purpura with intravenous immunoglobulin. Klin Wochenschr 1987; 65:369-372.
31. Godeau B, Caulier MT, Decuypere L, Rose C, Schaeffer A, Bierling P. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w. Br J Haematol1999; 107:716-719.
32. Stangel M, Hartung HP, Marx P, Gold R. Side effects of high-dose intravenous immunoglobulins. Clin Neuropharmacol 1997; 20:385-393.